UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent Developments in Myelodysplastic Syndromes

Fuchs, Ota

2019

Volltextzugriff (PDF)

Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple Myeloma

Cardiovascular & hematological disorders drug targets, 2013-03, Vol.13 (1), p.16-34

Fuchs, Ota

2013

Volltextzugriff (PDF)

Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

Current molecular pharmacology, 2010-11, Vol.3 (3), p.98-122

Fuchs, Ota

2010

Volltextzugriff (PDF)

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Cardiovascular & hematological disorders drug targets, 2019, Vol.19 (1), p.51-78

Fuchs, Ota

2019

Volltextzugriff (PDF)

Multiple Myeloma

Fuchs, Ota

2021

Volltextzugriff (PDF)

Targeting cereblon in hematologic malignancies

Blood reviews, 2023-01, Vol.57, p.100994-100994, Article 100994

Fuchs, Ota

2023

Volltextzugriff (PDF)

Preclinical Studies of PROTACs in Hematological Malignancies

Cardiovascular & hematological disorders drug targets, 2021, Vol.21 (1), p.7-22

2021

Volltextzugriff (PDF)

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations

International journal of molecular sciences, 2019-06, Vol.20 (11), p.2823

2019

Volltextzugriff (PDF)

Myelodysplastic Syndromes

2016

Volltextzugriff (PDF)

Cells of the Immune System

Ota Fuchs, Seyyed Shamsadin Athari

2020

Volltextzugriff (PDF)

Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia

PloS one, 2015-05, Vol.10 (5), p.e0127637-e0127637

2015

Volltextzugriff (PDF)

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

PloS one, 2018-12, Vol.13 (12), p.e0204290-e0204290

2018

Volltextzugriff (PDF)

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes

Molecular oncology, 2020-10, Vol.14 (10), p.2403-2419

2020

Volltextzugriff (PDF)

Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy

Current signal transduction therapy, 2011-01, Vol.6 (1), p.44-54

Fuchs, Ota

2011

Volltextzugriff (PDF)

Important Genes in the Pathogenesis of 5q- Syndrome and Their Connection with Ribosomal Stress and the Innate Immune System Pathway

Leukemia Research and Treatment, 2012-01, Vol.2012 (2012), p.43-56

2012

Volltextzugriff (PDF)

Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases

Current signal transduction therapy, 2011-01, Vol.6 (1), p.29-43

Fuchs, Ota

2011

Volltextzugriff (PDF)

Targeting the phosphatidylinositol 3-kinase signaling pathway in acute myeloid leukemia

Integrative cancer science and therapeutics, 2020, Vol.7 (4)

Fuchs, Ota

2020

Volltextzugriff (PDF)

Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib‑based therapy

Polskie archiwum medycyny wewne̦trznej, 2017-06, Vol.127 (6), p.386-387

Fuchs, Ota

2017

Volltextzugriff (PDF)

Immunomodulatory drugs and their therapeutic effect in hematological malignancies through cereblon

Hematology & Medical Oncology, 2017, Vol.2 (3)

Fuchs, Ota

2017

Volltextzugriff (PDF)

Arsenic Trioxide Upregulates Cereblon mRNA Expression and Potentiates Sensitivity of SKM-1 and MDS-L Cells to Lenalidomide

Blood, 2019-11, Vol.134 (Supplement_1), p.5397-5397

2019

Volltextzugriff (PDF)

Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells

Cardiovascular & hematological disorders drug targets, 2009-03, Vol.9 (1), p.62-77

2009

Volltextzugriff (PDF)

PD-L1 Is Frequently Expressed in Acute Myeloid Leukemia Patients with Leukocytosis

Blood, 2016-12, Vol.128 (22), p.5229-5229

2016

Volltextzugriff (PDF)

Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma

Cardiovascular & hematological disorders drug targets, 2013-03, Vol.13 (1), p.16

Fuchs, Ota

2013

Volltextzugriff (PDF)

Lenalidomide Therapy of Myelodysplastic Syndromes

Journal of Leukemia, 2013, Vol.1 (1)

Fuchs, Ota

2013

Volltextzugriff (PDF)

Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

Current molecular pharmacology, 2010-07, Vol.999 (999), p.1-25

Fuchs, Ota

2010

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(74)
Tschechisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent Developments in Myelodysplastic Syndromes

Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple Myeloma

Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Multiple Myeloma

Targeting cereblon in hematologic malignancies

Preclinical Studies of PROTACs in Hematological Malignancies

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations

Myelodysplastic Syndromes

Cells of the Immune System

Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes

Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy

Important Genes in the Pathogenesis of 5q- Syndrome and Their Connection with Ribosomal Stress and the Innate Immune System Pathway

Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases

Targeting the phosphatidylinositol 3-kinase signaling pathway in acute myeloid leukemia

Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib‑based therapy

Immunomodulatory drugs and their therapeutic effect in hematological malignancies through cereblon

Arsenic Trioxide Upregulates Cereblon mRNA Expression and Potentiates Sensitivity of SKM-1 and MDS-L Cells to Lenalidomide

Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells

PD-L1 Is Frequently Expressed in Acute Myeloid Leukemia Patients with Leukocytosis

Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma

Lenalidomide Therapy of Myelodysplastic Syndromes

Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

Suchergebnisse filtern